Status: Not yet recruiting
A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution
This clinical study is to evaluate the biodistribution of \[89Zr\]-Oxine-NCR100 injection in subjects with knee osteoarthritis after local injection and the kinetic behavior characteristics of zirconium-labeled cells at the injection site and various organs or tissues. It is a single-dose, open-label study in adult KOA subjects.
Participants needed: 6
Trial details
Phase: Phase 1Age: 40-70Biological sex: MaleType: InterventionalSponsor: Nuwacell Biotechnologies Co., Ltd.Updated: Aug 24, 2025
Eligibility criteria
Subjects who understand and voluntarily sign the Informed Consent Form(ICF) befo...
Subjects previously diagnosed with secondary knee osteoarthritis, or those diagn...